MedKoo Cat#: 125358 | Name: Quinocide phosphoric acid

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Quinocide is a biochemical for proteomics research

Chemical Structure

Quinocide phosphoric acid
Quinocide phosphoric acid
CAS#64992-36-5 (phosphoric acid)

Theoretical Analysis

MedKoo Cat#: 125358

Name: Quinocide phosphoric acid

CAS#: 64992-36-5 (phosphoric acid)

Chemical Formula: C15H24N3O5P

Exact Mass: 357.1500

Molecular Weight: 357.35

Elemental Analysis: C, 50.42; H, 6.77; N, 11.76; O, 22.39; P, 8.67

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Quinocide phosphoric acid; 70B6GZ7RYZ; UNII-70B6GZ7RYZ; WR-152149; N-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine phosphoric acid (1:1)
IUPAC/Chemical Name
N1-(6-methoxyquinolin-8-yl)pentane-1,4-diamine phosphate
InChi Key
IRHHRTPJHMOYBL-UHFFFAOYSA-N
InChi Code
InChI=1S/C15H21N3O.H3O4P/c1-11(16)5-3-7-17-14-10-13(19-2)9-12-6-4-8-18-15(12)14;1-5(2,3)4/h4,6,8-11,17H,3,5,7,16H2,1-2H3;(H3,1,2,3,4)
SMILES Code
OP(O)(O)=O.COC1=CC2=C(N=CC=C2)C(NCCCC(C)N)=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 357.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Elbashir AA, Saad B, Ali AS, Saleh MI, Aboul-Enein HY. Determination of quinocide as impurity in primaquine tablets by capillary zone electrophoresis. Biomed Chromatogr. 2009 May;23(5):464-71. doi: 10.1002/bmc.1137. PMID: 19016231. 2: Brondz I, Fialkov AB, Amirav A. Analysis of quinocide in unprocessed primaquine diphosphate and primaquine diphosphate tablets using gas chromatography-mass spectrometry with supersonic molecular beams. J Chromatogr A. 2009 Jan 30;1216(5):824-9. doi: 10.1016/j.chroma.2008.11.043. Epub 2008 Nov 21. Erratum in: J Chromatogr A. 2009 Mar 20;1216(12):2609-10. PMID: 19108846. 3: LYSENKO AY. Use of quinocide in treatment and prophylaxis of vivax malaria. Bull World Health Organ. 1960;22(6):641-62. PMID: 14419205; PMCID: PMC2555349. 4: MARUASHVILI GM, BAKRADZE TL, KANDELAKI NS, VEKUA MA, KARDAVA AG. Lechenie bol'nykh maliariei khinotsidom [Quinocide therapy of malaria]. Med Parazitol (Mosk). 1958 Jul-Aug;27(4):406-8. Russian. PMID: 13589459. 5: Brondz I, Ekeberg D, Bell DS, Annino AR, Hustad JA, Svendsen R, Vlachos V, Oakley P, Langley GJ, Mohini T, Amaury CG, Mikhalitsyn F. Nature of the main contaminant in the drug primaquine diphosphate: SFC and SFC-MS methods of analysis. J Pharm Biomed Anal. 2007 Feb 19;43(3):937-44. doi: 10.1016/j.jpba.2006.09.017. Epub 2006 Oct 31. PMID: 17079107. 6: Elbashir AA, Saad B, Ali AS, Saleh MI, Aboul-Enein HY. Enantioselective analysis of primaquine and its impurity quinocide by capillary electrophoresis. Biomed Chromatogr. 2009 Mar;23(3):295-301. doi: 10.1002/bmc.1113. PMID: 18816453. 7: Elbashir AA, Suliman FE, Saad B, Aboul-Enein HY. Capillary electrophoretic separation and computational modeling of inclusion complexes of beta- cyclodextrin and 18-crown-6 ether with primaquine and quinocide. Biomed Chromatogr. 2010 Apr;24(4):393-8. doi: 10.1002/bmc.1304. PMID: 19650150. 8: Brondz I, Mantzilas D, Klein U, Ekeberg D, Hvattum E, Lebedeva MN, Mikhailitsyn FS, Souleimanov GD, Røe J. Nature of the main contaminant in the anti malaria drug primaquine diphosphate: a qualitative isomer analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Feb 5;800(1-2):211-23. doi: 10.1016/j.jchromb.2003.09.042. PMID: 14698257. 9: Németh K, Tárkányi G, Varga E, Imre T, Mizsei R, Iványi R, Visy J, Szemán J, Jicsinszky L, Szente L, Simonyi M. Enantiomeric separation of antimalarial drugs by capillary electrophoresis using neutral and negatively charged cyclodextrins. J Pharm Biomed Anal. 2011 Feb 20;54(3):475-81. doi: 10.1016/j.jpba.2010.09.020. Epub 2010 Sep 19. PMID: 20943339. 10: TIBURSKAIA NA, GLADKIKH VF, GRINBERG EM. [Data on the studies of the organ of vision following administration of quinocide]. Med Parazitol (Mosk). 1959 Jul-Aug;28:454-6. Russian. PMID: 13838302.